Results 101 to 110 of about 37,507 (250)

Serial Change and Clinical Impact of Irregular Protrusion in Lesions With Chronic Coronary Syndrome

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 5, Page 1149-1160, April 1, 2025.
ABSTRACT Background The changes over time and effects on long‐term clinical outcomes beyond 1 year of irregular protrusion (IP) in chronic coronary syndrome (CCS) remains unclear. Aims This study aimed to assess the time‐dependent change and long‐term clinical impact of IP in CCS lesions.
Naotaka Okamoto   +13 more
wiley   +1 more source

Bioresorbable vascular scaffold for very late stent thrombosis resulting from ruptured neoatherosclerosis

open access: yesRevista Portuguesa de Cardiologia, 2015
Very late stent thrombosis is a rare but devastating complication after percutaneous coronary revascularization. Pathological studies have demonstrated that neoatherosclerosis plays a major role in certain patients with very late stent thrombosis ...
Teresa Bastante   +6 more
doaj  

Hemodynamics of Stent Implantation Procedures in Coronary Bifurcations: an in vitro study [PDF]

open access: yesarXiv, 2016
Stent implantation in coronary bifurcations presents unique challenges and currently there is no universally accepted stent deployment approach. Despite clinical and computational studies, to date, the effect of each stent implantation method on the coronary artery hemodynamics is not well understood.
arxiv  

Novel Transthoracic Pulmonary Valve Implantation Using Self‐Expanding Salus Valve: A Prospective Study of Safety and Mid‐Term Outcomes

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter pulmonary valve replacement (TPVR) has emerged as a valuable treatment for severe pulmonary regurgitation (PR). The Salus valve (Balance Medical Technology Co. Ltd., Beijing, China) represents a novel self‐expanding valve stent designed for deployment through a transthoracic approach with a small subxiphoid incision ...
Ziqin Zhou   +6 more
wiley   +1 more source

A Case of Stent Fracture and Very Late Stent Thrombosis 15 Months after Drug-Eluting Stent Implantation

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul, 2009
BACKGROUND AND OBJECTIVE: Stent fracture (SF), in peripheral vessels and although in coronary arteries has been reported. Very late and after one year stent thrombosis in drug eluting stent (DES) is a rare phenomenon and its most frequent cause is ...
A Ghaemian,, M Saravi
doaj  

Bioresorbable Scaffold Visualization in IVOCT Images Using CNNs and Weakly Supervised Localization [PDF]

open access: yesarXiv, 2018
Bioresorbable scaffolds have become a popular choice for treatment of coronary heart disease, replacing traditional metal stents. Often, intravascular optical coherence tomography is used to assess potential malapposition after implantation and for follow-up examinations later on.
arxiv  

Impact of Diabetes on Long‐Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) is a well‐known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
Subin Lim   +31 more
wiley   +1 more source

Drug-eluting stent thrombosis in the treatment of chronic total coronary occlusions: Incidence, presentation and related factors. Data from the CIBELES trial

open access: yesRevista Portuguesa de Cardiologia, 2015
Introduction and Objectives: The aim of this study was to analyze the incidence of drug-eluting stent thrombosis (sirolimus or everolimus) in patients with chronic total coronary occlusions (CTO) and to determine its clinical implications and related ...
Eduardo Arroyo-Úcar   +22 more
doaj  

30‐Day DAPT in Patients at High Bleeding Risk Undergoing PCI With Biodegradable‐Polymer Sirolimus‐Eluting Ultra‐Thin Stent

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 6, Page 1502-1509, May 1, 2025.
ABSTRACT Background There is limited evidence on the safety and efficacy of biodegradable‐polymer sirolimus‐eluting ultra‐thin stent (BP‐SES) in patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI). Aims This study aims to evaluate the clinical outcomes of HBR patients treated with BP‐SES and ≤ 30‐day dual ...
Andrea Erriquez   +9 more
wiley   +1 more source

The Impact of Underlying Plaque Characteristics Following the Third‐Generation Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Assessment up to 12‐Months

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Third‐generation resorbable magnesium scaffold (RMS) was developed with stronger mechanical properties and thinner struts compared to its predecessor. This study aimed to assess the influence of the OCT‐derived underlying plaque characteristics on in‐scaffold late lumen loss (LLL) in patients treated with RMS up to 12‐months ...
Alp Aytekin   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy